Aplastic anemia - Open Access .click

Results 151 to 160 of about 181,406 (245)

Posaconazole Target Attainment in Critically Ill Children: A 15‐Year Single‐Center Retrospective Analysis

Clinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Posaconazole is a triazole antifungal agent used for prophylaxis and treatment of invasive fungal diseases. Posaconazole has high inter‐individual variability in dose‐exposure relationship and benefits from therapeutic drug monitoring (TDM). Adult studies report particularly high rates of subtherapeutic exposure among intensive care unit (ICU)
Kathryn Pavia, Addison Pritchett, Jennifer Goldman +2 more
wiley +1 more source

Current management of severe acquired aplastic anemia [PDF]

, 2011
Overall survival in severe aplastic anemia has markedlyimproved in the past four decades due to advances in stem celltransplantation, immunosuppressive therapies and supportive care.Horse anti-thymocyte globulin plus cyclosporine is the ...
Phillip Scheinberg
core

[Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].

Terapevticheskii arkhiv, 1999
To validate up-to-date policy of immunosuppressive therapy of patients with aplastic anemia (AA) which has developed either at acute or chronic phase of viral hepatitis.16 patients with AA detected within 6 months (9 patients) or 12-36 months (7 patients) after acute viral hepatitis received immunosuppressive therapy (antilymphocytic globulin ...
E A, Mikhaĭlova, V N, Iadrikhinskaia, V G, Savchenko +2 more
openaire +1 more source

Reconceptualizing Aplastic Anemia-Seed, Worm, Soil. [PDF]

J Clin Lab Anal
Xu X, Wang Z, Hu J, Liu C, Fu R.
europepmc +1 more source

Severe aplastic anemia as a rare autoimmune complication of ankylosing spondylitis: A rare case report. [PDF]